Liver MRI is not accurate enough to definitely identify patients with iron overload.
Magnetic resonance imaging of the liver may help rule out iron overload, but is not accurate enough to definitely identify patients with the condition, according to an article published in the journal Clinical Gastroenterology and Hepatology.
Researchers from Greece sought to determine if using MRI could help identify patients with iron overload and to guide titration of chelation therapy. Their systematic review and meta-analysis was based on patients with hereditary hemochromatosis, hemoglobinopathy and myelodysplastic syndrome.
A total of 20 studies with 819 patients were chosen for the final analysis. The researchers found that sensitivity and specificity values varied greatly, ranging from 0.00 to 1.00 and from 0.50 to 1.00, respectively.
“Due to substantial heterogeneity and variable positivity thresholds, we calculated only summary receiver operating curves (and summary estimate points for studies that used the same MRI sequences). T2 spin echo and T2* gradient-recalled echo MRI sequences accurately identified patients without liver iron overload (liver iron concentration > 7 mg Fe/g dry liver weight) (negative likelihood ratios, 0.10 and 0.05 respectively),” the authors wrote. “However, these MRI sequences are less accurate in establishing a definite diagnosis of liver iron overload (positive likelihood ratio of 8.85 and 4.86 respectively).”
The authors concluded that while the MRI measurements of iron concentration in the liver may be accurate enough to rule out iron overload, the measurements were not accurate enough to definitely identify patients who may be overloaded.
FDA Clears Remote Scanning Support Platform for MRI, CT and PET/CT
March 25th 2024The multimodality system nCommand Lite reportedly facilitates real-time remote imaging guidance on scanning parameters and procedure assessments to licensed technologists for a variety of imaging modalities including CT and MRI.
Study: PET/MRI May Prevent Up to 83 Percent of Unnecessary Biopsies in Men with PI-RADS 3 Lesions
March 15th 2024For men with PI-RADS 3 lesions, PRIMARY scores of 4-5 with PET/MRI had a sensitivity rate of 87.5 percent for clinically significant prostate cancer, according to newly published research.